Compare SAWAI GROUP HOLDINGS Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -5.16% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate -5.16% of over the last 5 years
3
Positive results in Jun 26
4
With ROCE of 7.62%, it has a expensive valuation with a 1.05 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 194,076 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.43
6.46%
1.09
Revenue and Profits:
Net Sales:
63,566 Million
(Quarterly Results - Jun 2026)
Net Profit:
3,525 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.89%
0%
-0.89%
6 Months
-22.83%
0%
-22.83%
1 Year
-17.87%
0%
-17.87%
2 Years
-72.28%
0%
-72.28%
3 Years
-63.47%
0%
-63.47%
4 Years
-58.57%
0%
-58.57%
5 Years
-68.17%
0%
-68.17%
SAWAI GROUP HOLDINGS Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.95%
EBIT Growth (5y)
-5.16%
EBIT to Interest (avg)
19.55
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.66
Tax Ratio
19.18%
Dividend Payout Ratio
60.84%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.16%
ROE (avg)
4.67%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.07
EV to EBIT
13.73
EV to EBITDA
13.73
EV to Capital Employed
1.05
EV to Sales
1.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.62%
ROE (Latest)
-0.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
63,566.30
46,812.00
35.79%
Operating Profit (PBDIT) excl Other Income
6,257.90
243.00
2,475.27%
Interest
692.00
529.00
30.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,525.40
654.00
439.05%
Operating Profit Margin (Excl OI)
98.40%
5.20%
9.32%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 35.79% vs -16.44% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 439.05% vs -86.58% in Mar 2026
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
201,676.00
189,024.00
6.69%
Operating Profit (PBDIT) excl Other Income
36,352.00
35,481.00
2.45%
Interest
1,757.00
1,039.00
69.10%
Exceptional Items
-3,979.00
-16,757.00
76.25%
Consolidate Net Profit
11,536.00
2,173.00
430.88%
Operating Profit Margin (Excl OI)
100.90%
107.10%
-0.62%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 6.69% vs 6.88% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 430.88% vs -82.86% in Mar 2025
About SAWAI GROUP HOLDINGS Co., Ltd. 
SAWAI GROUP HOLDINGS Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






